SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure 
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing 
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions 
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure 
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide 
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids 
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper 
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation 
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio 
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns 
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs 
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles 
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip 
Dublin, Dec. 23, 2016 -- Research and Markets has announced the addition of the "Osteoarthritis Drugs Price Analysis and Strategies - 2016" report to their offering.
Osteoarthritis Drugs Price Analysis and Strategies 2016, provides drug pricing data and benchmarks in the global Osteoarthritis market.
The research answers the following questions:
- What are the key drugs marketed for Osteoarthritis and their clinical attributes? How are they positioned in the Global Osteoarthritis market?
- What are the unit prices and annual treatment cost for Osteoarthritis therapies in different countries? What are the drug pricing trends and how are they expected to change in the future? How are the drug pricing and reimbursement landscape different by countries?
- What are the unmet needs in the global Osteoarthritis drugs market? What would be the ideal pricing strategy for a new pipeline therapy for Osteoarthritis?
Research Scope:
- Treatment Options - Identify key drugs marketed and prescribed for Osteoarthritis including trade name, molecule name, and company
- Drugs Attributes - Find out the safety, efficacy, and risk benefit for key drugs marketed for Osteoarthritis
- Market Positioning - Identify how drugs are clinically and commercially positioned in the global Osteoarthritis market
- Osteoarthritis Drugs Price Analysis - Find out the annual therapy cost and unit price for key drugs marketed
- Find out how the price advanced from 2012 and forecast to 2021
- Pricing & Reimbursement Landscape - Find out the pricing and reimbursement landscape
- Osteoarthritis New Drug Pricing - Identify the effective pricing strategy for a new drug launch
Key Topics Covered:
1. Treatment Options
2. Drugs Clinical Attributes
3. Drugs Market Positioning
4. Drugs Price Analysis
5. Drugs Price Benchmarks
6. Drug Pricing & Reimbursement Landscape
7. Drugs Price Forecast
8. Market Unmet Needs
9. New Drug Pricing
For more information about this report visit http://www.researchandmarkets.com/research/dlzhk2/osteoarthritis
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Immune Disorders Drugs, Musculoskeletal Disorders Drugs
